Levocarnitine and Bactrim ds drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine and Bactrim ds. Common interactions include headache among females and bronchopulmonary aspergillosis among males.

The phase IV clinical study analyzes what interactions people who take Levocarnitine and Bactrim ds have. It is created by eHealthMe based on reports of 18 people who take Levocarnitine and Bactrim ds from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 27, 2022

18 people who take Levocarnitine and Bactrim ds together, and have interactions are studied.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 2,363 Levocarnitine users for its effectiveness, alternative drugs and more.

What is Bactrim ds?

Bactrim ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 15,287 Bactrim ds users for its effectiveness, alternative drugs and more.

Number of Levocarnitine and Bactrim ds reports submitted per year:

Common Levocarnitine and Bactrim Ds drug interactions by gender *:

female:

Headache
Pruritus

male:

Bronchopulmonary aspergillosis
Cellulitis
Systemic inflammatory response syndrome
Sepsis
Diarrhoea
Hepatic steatosis
Hepatitis
Hospitalisation
Hyperkalaemia
Hypertriglyceridaemia

Common Levocarnitine and Bactrim Ds drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Bronchopulmonary aspergillosis
Cellulitis
Escherichia bacteraemia
Febrile neutropenia
Hyperglycaemia
Myositis
Parainfluenzae virus infection
Pneumonia
Septic shock
Diarrhoea

20-29:

n/a

30-39:

Hepatitis
Hospitalisation
Pancreatitis

40-49:

Pyrexia
Systemic inflammatory response syndrome
Sepsis

50-59:

Pyrexia
Systemic inflammatory response syndrome

60+:

Headache
Pruritus

Common conditions people have *:

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 9 people, 50.00%
Multiple Myeloma (cancer of the plasma cells): 7 people, 38.89%
Pain: 6 people, 33.33%
Nausea (feeling of having an urge to vomit): 6 people, 33.33%
Muscle Spasms (muscle contraction): 5 people, 27.78%
Constipation: 5 people, 27.78%
Non-Hodgkin's Lymphoma Refractory (refractory malignant (cancer) cells form in the lymph system): 1 person, 5.56%
Nausea And Vomiting: 1 person, 5.56%
Insomnia (sleeplessness): 1 person, 5.56%
Indigestion: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Bactrim ds?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.